MOF‐Immobilized Two‐in‐One Engineered Enzymes Enhancing Activity of Biocatalytic Cascade for Tumor Therapy
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202203035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Caiqi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Engineering Technology Research Center of Drug Carrier of Guangdong, Departm…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Zeolites. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Biocatalytic systems based on enzyme cascade reactions have attracted growing interest in the field of biocatalytic medicine. However, it is a major challenge to reasonably construct enzyme cascade reactions with high stability, selectivity, and catalytic efficiency for the in vivo biocatalytic application. Herein, two‐in‐one engineered glucose oxidase (GOx‐Fe 0 ) is fabricated by a biomineralization strategy, through which a nanozyme (Fe 0 NP) is anchored within the inner cavity of GOx. Then, GOx‐Fe 0 is immobilized in a pH‐sensitive metal–organic framework (MOF) zeolitic imidazolate framework‐8 (ZIF‐8) to establish a stable and effective MOF‐immobilized two‐in‐one engineered enzyme, GOx‐Fe 0 @ZIF‐8. In vitro studies show that GOx‐Fe 0 @ZIF‐8 exhibits excellent stability and high pH/glucose selectivity, and the shorter spacing between cascade enzymes can increase the cascade throughput and effectively improve the reaction efficiency of the enzyme cascade. In vivo experiments exhibit that GOx‐Fe 0 @ZIF‐8 solves the instability and systemic toxicity of free enzymes, and achieves deep tumor penetration and significant chemodynamic therapeutic efficacy through a pH/glucose‐selective enzyme cascade reaction in tumor site. Taken together, such an orchestrated enzyme engineering strategy can effectively improve enzyme stability, selectivity, and enzyme cascade reaction efficiency via chemical transformations, and also provide a promising strategy for the application of biocatalytic cascade reactions in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Engineering Technology Research Center of Drug Carrier of Guangdong, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, Ch…
ORCID-Profile: Jian Dai
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Fundamental Research Funds for the Central Universities
- China Postdoctoral Science Foundation
Zitieren
APA
Yang, C., Liu, W., Chen, S., Zong, X., Yuan, P., Chen, X., Li, X., Li, Y., Xue, W., & Dai, J. (2023). MOF‐Immobilized Two‐in‐One Engineered Enzymes Enhancing Activity of Biocatalytic Cascade for Tumor Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202203035
Vancouver
Yang C, Liu W, Chen S, Zong X, Yuan P, Chen X, et al. MOF‐Immobilized Two‐in‐One Engineered Enzymes Enhancing Activity of Biocatalytic Cascade for Tumor Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202203035
BibTeX
@article{Yang2023,
author = {Yang, Caiqi and Liu, Wen and Chen, Shanfeng and Zong, Xiaoqing and Yuan, Pengfei and Chen, Xinjie and Li, Xiaodi and Li, Yuchao and Xue, Wei and Dai, Jian},
title = {MOF‐Immobilized Two‐in‐One Engineered Enzymes Enhancing Activity of Biocatalytic Cascade for Tumor Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202203035}
}
EUVIMED